The risks of using non-specific outcome measures to capture activities of daily living in myotonic dystrophy type 2.

Hamadeh, Tatiana; Bovenkerk, David S H; Faber, Catharina G; Merkies, Ingemar S J

Hamadeh, Tatiana; Bovenkerk, David S H; Faber, Catharina G; Merkies, Ingemar S J.

Affiliation

Hamadeh T; Department of Neurology, Maastricht University Medical Center, P.O. Box 5800, Maastricht, the Netherlands. Electronic address: t.hamadeh@maastrichtuniversity.nl.
Bovenkerk DSH; Department of Neurology, Maastricht University Medical Center, P.O. Box 5800, Maastricht, the Netherlands.
Faber CG; Department of Neurology, Maastricht University Medical Center, P.O. Box 5800, Maastricht, the Netherlands.
Merkies ISJ; Department of Neurology, Maastricht University Medical Center, P.O. Box 5800, Maastricht, the Netherlands; Department of Neurology, Curacao Medical Center, J.H.J. Hamelbergweg z/n, Willemstad, Curaçao.

Neuromuscul Disord ; 31(4): 367-368, 2021 04.

Article de En | MEDLINE | ID: mdl-33741224

Sujet(s)

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Activités de la vie quotidienne / Dystrophie myotonique Type d'étude: Etiology_studies / Risk_factors_studies Limites: Humans Langue: En Journal: Neuromuscul Disord Sujet du journal: NEUROLOGIA Année: 2021 Type de document: Article

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google